State Street’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,090
Closed -$26.6K 4583
2023
Q3
$26.6K Hold
8,090
﹤0.01% 4409
2023
Q2
$41.4K Buy
8,090
+7,320
+951% +$35.8K ﹤0.01% 4464
2023
Q1
$3.38K Hold
770
﹤0.01% 4775
2022
Q4
$3.44K Hold
770
﹤0.01% 4843
2022
Q3
$12K Hold
770
﹤0.01% 4885
2022
Q2
$36K Buy
+770
New +$44.6K ﹤0.01% 4792

State Street's UTRS Position: Q4 2023 in Review

State Street sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 8,090 shares — an estimated $26.6K sold.

State Street first reported a position in UTRS in Q2 2022 and held it in 6 quarters. The position peaked at $41.4K in Q2 2023. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

  • State Street reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • State Street sold 8,090 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $26.6K.
  • State Street first reported a position in Minerva Surgical, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • State Street's Minerva Surgical, Inc. Common Stock position peaked at $41.4K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.